Evidence map›Paper›PMID 17369507›Full record

ReviewJournal of clinical pathology2007

Nodal aggressive B-cell lymphomas: a diagnostic approach.

Sonam Prakash, Steven H Swerdlow

Abstract readReview
In one paragraph

Review in Journal of clinical pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sonam PrakashDivision of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Steven H Swerdlow

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diffuse aggressive B-cell lymphomas, as recognised in the 2001 WHO classification, represent a clinically and biologically heterogeneous group of neoplasms that require very different therapeutic approaches and have very different outcomes. They should be diagnosed using a multiparameter approach that emphasises morphological and immunophenotypic studies, and in at least some cases, relies on cytogenetic and/or genotypic studies. Incorporation of clinical data may be important as well. There is also current interest in going beyond the basic diagnosis and providing pathological prognostic information when possible. Whereas the diagnosis of some cases will be relatively easy, the differential diagnosis in others is very difficult, with some cases in a grey zone between two different well defined categories.

Indexed as

Anaplastic Lymphoma KinaseBiomarkers, TumorBiopsyChromosome AberrationsDiagnosis, DifferentialHumansImmunophenotypingLymph NodesLymphoma, Large B-Cell, DiffusePrognosisProtein-Tyrosine KinasesReceptor Protein-Tyrosine KinasesAnaplastic Lymphoma KinaseBiomarkers, TumorProtein-Tyrosine KinasesReceptor Protein-Tyrosine Kinases

Identifiers

PMID17369507
PMCPMC2014851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.